Abingworth portfolio company GammaDelta Therapeutics to be a

/PRNewswire/ -- Abingworth, a leading international life sciences investor, announces its portfolio company GammaDelta Therapeutics is to be acquired by Takeda...

Related Keywords

Boston , Massachusetts , United States , Lisbon , Lisboa , Portugal , United Kingdom , London , City Of , Oliver Nussbaumer , Eleanor Perkin , Tim Haines , Bruno Silva Santos , Adrian Hayday , Paolo Paoletti , Prnewswire Abingworth , King College London , University Of Lisbon , St Thoma Biomedical Research Centre , Cancer Research United Kingdom Commercial Partnerships , National Institute For Health Research Guy , Takeda Pharmaceutical Company Limited , Francis Crick Institute , Cancer Research Technology , Gammadelta Therapeutics , Delta Therapeutics , United Kingdom Headquartered , Professor Adrian Hayday , College London , Cancer Research , Abingworth Chair , Managing Partner , Board Member , Menlo Park , Professor Bruno Silva Santos , National Institute , Health Research Guy , Cancer Research United Kingdom Commercial , Abingworth ,